论文信息 - Outcomes of surgical management for borderline (BR)/locally advanced (LA) pancreatic adenocarcinoma (PAC) after neoadjuvant FOLFIRINOX chemotherapy: Results of an AGEO/French multicenter study.

Outcomes of surgical management for borderline (BR)/locally advanced (LA) pancreatic adenocarcinoma (PAC) after neoadjuvant FOLFIRINOX chemotherapy: Results of an AGEO/French multicenter study.

e15250 Background: FOLFIRINOX has been shown to increase survival in patients with metastatic PAC with an objective response rate of 32%. In BR and LA PAC, a resection rate of 36% has been reported...